急性心肌梗死的药物溶栓和介入治疗.pptVIP

Procedural characteristics (n=46) Glycoprotein IIb/IIIa use, - no.(%) 7 ( 15.2 % ) Thrombectomy, - no.(%) 0 ( 0 % ) Coronary-artery bypass grafting, - no.(%) 0 ( 0 % ) Distal protection device, - no.(%) 0 ( 0 % ) Coronary stents, - no.(%) 45 ( 97.8 % ) Complications - no.(%) Minor dissection 1 ( 2.2 % ) No reflow 2 ( 4.3 % ) (PPCI 5-25%) Improved TIMI grade flow 48.5±32.1 37.9±25.6 p＝0.01 Improved CTFC Improved MBG 59.7±37.2 26.7±19.9 36.9±23.4 37.8±21.5 n=12 n=8 n=15 n=11